Related Experiment Videos
Risk of breast cancer in carriers of BRCA gene mutations
The New England Journal of Medicine
|September 11, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Cancer treatment reports·1984
Posttransfusion purpura. Case report with observation on antibody detection and therapy.
Archives of internal medicine·1978
Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer.
The New England journal of medicine·2026
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC.
The New England journal of medicine·2026
Osimertinib-Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy.
The New England journal of medicine·2026
Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer.
The New England journal of medicine·2026
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer.
The New England journal of medicine·2026
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C-Mutated NSCLC.
The New England journal of medicine·2026
BCOR Biology in Development and Cancer.
Cells·2026
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship.
Journal of the National Cancer Institute·2026
Nutrimental Determinants of Chronological Aging and Competitiveness in the snf1Δ Warburg Model.
Yeast (Chichester, England)·2026
How Multidisciplinary are Case Discussions in Tumor Conferences of Breast and Gynecological Cancer Patients in German Cancer Centers?
Journal of multidisciplinary healthcare·2026